Skip to main navigation Skip to search Skip to main content

Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients

  • K Sennvik
  • , J Fastbom
  • , M Blomberg
  • , L O Wahlund
  • , B Winblad
  • , E Benedikz

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Alternative cleavage of the amyloid precursor protein (APP) results in generation and secretion of both soluble APP (sAPP) and beta-amyloid (Abeta). Abeta is the main component of the amyloid depositions in the brains of Alzheimer's disease (AD) patients. Using Western blotting, we compared the levels of alpha-secretase cleaved sAPP, beta-secretase cleaved sAPP and total sAPP, in cerebrospinal fluid (CSF) from 13 sporadic AD patients and 13 healthy controls. Our findings show significant amounts of beta-secretase cleaved sAPP in CSF. There was no statistically significant difference in the levels of beta-secretase cleaved sAPP between AD patients and controls. The levels of alpha-secretase cleaved sAPP and total sAPP were, however, found to be significantly lower in the AD patients than in the controls.

Original languageEnglish
JournalNeuroscience Letters
Volume278
Issue number3
Pages (from-to)169-72
Number of pages4
ISSN0304-3940
Publication statusPublished - 14 Jan 2000
Externally publishedYes

Keywords

  • Aged
  • Alzheimer Disease
  • Amyloid Precursor Protein Secretases
  • Amyloid beta-Protein Precursor
  • Aspartic Acid Endopeptidases
  • Blotting, Western
  • Endopeptidases
  • Female
  • Humans
  • Journal Article
  • Male
  • Middle Aged
  • Reference Values
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients'. Together they form a unique fingerprint.

Cite this